NYSE:IQV IQVIA Q2 2026 Earnings Report $209.18 +5.39 (+2.64%) Closing price 07/9/2026 03:59 PM EasternExtended Trading$206.06 -3.12 (-1.49%) As of 07/9/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast IQVIA EPS ResultsActual EPSN/AConsensus EPS $3.03Beat/MissN/AOne Year Ago EPSN/AIQVIA Revenue ResultsActual RevenueN/AExpected Revenue$4.30 billionBeat/MissN/AYoY Revenue GrowthN/AIQVIA Announcement DetailsQuarterQ2 2026Date7/28/2026TimeBefore Market OpensConference Call DateTuesday, July 28, 2026Conference Call Time9:00AM ETConference Call ResourcesEarnings HistoryCompany Profile IQVIA Earnings HeadlinesIQVIA (IQV) Just Drew A New Artisan Partners Bet On AI And ResilienceJuly 9 at 2:52 PM | finance.yahoo.comIQVIA to Announce Second-Quarter 2026 Results on July 28, 2026July 8 at 4:15 PM | businesswire.comTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free. | Reagan Gold Group (Ad)Is IQVIA Holdings (IQV) Resilient to AI Concerns?July 8 at 7:58 AM | finance.yahoo.comIQVIA Holdings Inc. (NYSE:IQV) Receives Consensus Rating of "Moderate Buy" from AnalystsJuly 5, 2026 | americanbankingnews.comThis life sciences stock has a secret weapon, and AI will only make it more valuableJune 24, 2026 | cnbc.comSee More IQVIA Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like IQVIA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IQVIA and other key companies, straight to your email. Email Address About IQVIAIQVIA (NYSE:IQV) (NYSE: IQV) is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. The company combines clinical research capabilities with large-scale health data and analytics to support drug development, regulatory reporting, commercial strategy and real‑world evidence generation. IQVIA traces its current form to the combination of Quintiles and IMS Health announced in 2016 and subsequently rebranded as IQVIA, bringing together long-established clinical research operations and extensive healthcare information assets. IQVIA’s principal activities include outsourced clinical development services (acting as a contract research organization for phases I–IV), real‑world evidence and observational research, regulatory and safety services, and a suite of technology platforms that enable data integration, analytics and operational management. The company maintains proprietary healthcare and commercial data assets and deploys analytics and machine learning to help clients identify patient populations, optimize trial design and accelerate product commercialization. In addition to trial execution, IQVIA offers consulting and commercialization services that support market access, medical affairs and performance improvement across product lifecycles. Operating globally, IQVIA serves pharmaceutical and biotechnology companies, medical device manufacturers, payers, providers and government agencies across more than 100 countries. Its combination of clinical services, data resources and software platforms positions the company to support customers from early development through post‑market evidence generation and commercial operations. Because leadership and operational details can change, readers should consult the company’s filings and corporate communications for the latest governance information.View IQVIA ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles PriceSmart Stock Eyes $220 as Chile Expansion Fuels GrowthLockheed Martin Secures the Ultimate Defense MoatWhy Levi's Digital Strategy Is Paying Off in a Big WayConstellation Brands: Beer Growth and Buybacks Mask Stock's SlumpWhy Exxon Could Be the Market's Next Big Comeback StockWhy Penguin Solutions May Be the Smartest AI Infrastructure StockMeta Platforms’ Cloud Push: Growth Opportunity Versus AI Concerns Upcoming Earnings Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026)Wells Fargo & Company (7/14/2026)Citigroup (7/14/2026)Fastenal (7/14/2026)Cintas (7/15/2026)ASML (7/15/2026)Kinder Morgan (7/15/2026)BlackRock (7/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
